🇺🇸 FDA
Pipeline program

Iluvien 0.19 MG Drug Implant

01-20-005

Approved small_molecule active

Quick answer

Iluvien 0.19 MG Drug Implant for Diabetic Macular Edema is a Approved program (small_molecule) at ANI PHARMACEUTICALS INC with 1 ClinicalTrials.gov record(s).

Program details

Company
ANI PHARMACEUTICALS INC
Indication
Diabetic Macular Edema
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials